Oncoinvent, a clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, today announced the successful enrollment of the sixth patient into the safety lead-in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback